FDA Approves Intravenous Version of Tesaro Drug for Chemotherapy Nausea FDA Approves Intravenous Version of Tesaro Drug for Chemotherapy Nausea
Tesaro Inc said on Wednesday that the U.S. Food and Drug Administration approved an intravenous version of its drug to treat chemotherapy-induced nausea and vomiting in adults.News Alerts
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer & Oncology | Chemotherapy | Food and Drug Administration (FDA) | Health | Hematology